Comparing Antibiotic Treatment Strategies for Children With Pneumonia in Outpatient Settings: (STAMPP)
Key facts
- Who runs it
- Ann & Robert H Lurie Children's Hospital of Chicago
- Where
- Atlanta, Chicago, Kansas City, Los Angeles, Philadelphia, Salt Lake City, San Diego, San Francisco, and Washington D.C., United StatesSee the 9 sites
- Trial code
- Status
- Recruiting
- People taking part
- 2,000 people, planned
- Started
- 9 Sept 2025
- Expected to end
- 16 Jul 2029
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Immediate Antibiotic Prescribing Group Instructions
- Safety Net Antibiotic Prescribing (SNAP) Group Instructions
- Record updated
- 17 November 2026
Who can take part
- Age
- 12 months to 71 months
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 23 criteriaShow less
Who can take part
- Aims 1 and 2:
- Presenting with signs and symptoms of lower respiratory tract infection
- Diagnosed with community-acquired pneumonia (CAP) by a clinician
- The treating clinician intends to prescribe antibiotics for CAP, AND
- Well enough, as determined by the clinician at the time of the study enrollment visit, to be managed as an outpatient
- Aim 3:
- Parent/guardian of child enrolled in the trial, OR
- Clinician who makes prescribing decision at the study site, OR
- Other practice-based parties (e.g. nurses, pharmacists, medical assistants, practice leaders) at study sites who can comment on the implementation of each prescribing strategy
Who cannot take part
- Hospitalization within the previous 7 days
- Incomplete immunization status (e.g., lacking at least 3 doses of the pneumococcal vaccines, typically given as part of the 2-, 4-, and 6-month vaccinations)
- Substantially immunocompromised status (e.g., immunodeficiency, active cancer treatment, organ transplant with concurrent immunosuppressive agents)
- Receipt of oral or parenteral antibiotics within the previous 7 days
- Pneumonia diagnosis within the previous 2 months, OR
- Prior enrollment in the trial
- Chronic medical conditions that increase the risk of bacterial CAP (e.g., chronic lung disease, cystic fibrosis, sickle cell disease),
- Known bacterial source of infection warranting immediate antibiotics
- Aims 1 and 2:
- Oxygen saturation below 90%, if measured
- Diagnosis of complicated pneumonia (e.g., empyema, lung abscess)
- Inability of the parent or guardian to speak English or Spanish
- Aim 3:
- Inability of the parent or guardian to speak English
Where in United States
- Children's Healthcare of AtlantaAtlanta, United StatesContact: Laura BeneditTaking people
- Ann & Robert H. Lurie Children's Hospital of ChicagoChicago, United StatesContact: Anne LakesTaking people
- Children's MercyKansas City, United StatesContact: Tammy BaseyNot yet recruiting
- Children's Hospital Los AngelesLos Angeles, United StatesContact: Anita SchmidtNot yet recruiting
- Children's Hospital of PhiladelphiaPhiladelphia, United StatesContact: Kellyann BaxendellTaking people
- Primary Children's HospitalSalt Lake City, United StatesContact: Todd Florin, MD, MSCENo longer taking part
- Rady Children's Hospital - San DiegoSan Diego, United StatesContact: Michelle JoyceNot yet recruiting
- UCSF Benioff Children's Hospital - San FranciscoSan Francisco, United StatesContact: Ryman CroneNot yet recruiting
- Children's National HospitalWashington D.C., United StatesContact: Bobbe ThomasNot yet recruiting
About the trial
What the trial wants to find out
The goal of this clinical trial is to determine if a "watch and wait" antibiotic strategy, called Safety Net Antibiotic Prescribing (SNAP), can safely reduce unnecessary antibiotic use while ensuring that children diagnosed with community-acquired pneumonia get better from their illness. The main aims of this study are:
Read full original descriptionShow less
* To compare the effectiveness of SNAP versus immediate antibiotic prescribing in children with mild community-acquired pneumonia (CAP) * To identify which patient groups benefit most from the SNAP strategy * To identify factors that shape implementation of each prescribing strategy.
Researchers will compare the SNAP strategy (where parents or guardians are instructed to give antibiotics only if their child is not improving after 72 hours, or sooner if they are worsening) to the immediate antibiotic prescribing strategy (where parents or guardians are instructed to give the antibiotics right after their healthcare visit) to see if one strategy is more effective than the other.
Participants will be randomly assigned to either the immediate antibiotic group or the SNAP group at enrollment. Participation lasts 14 days with follow-up surveys at 4, 7, and 14 days after enrollment.
The 2 groups in the trial
- Immediate Antibiotic PrescribingExisting treatment, for comparison
For participants randomized to this arm, a prescription is filled and the antibiotic is administered right after the index visit.
Treatment: Immediate Antibiotic Prescribing Group Instructions
- Safety Net Antibiotic Prescribing (SNAP)Other group
For participants randomized to this arm, a prescription is provided, but the patient is instructed not to take the antibiotic unless the child is not improving at 72 hours or sooner if getting worse.
Treatment: Safety Net Antibiotic Prescribing (SNAP) Group Instructions
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Comparing Antibiotic Treatment Strategies for Children With Community-Acquired Pneumonia in Outpatient Settings (Safety-Net Antibiotic Prescribing to Manage Pediatric Pneumonia [STAMPP])
- Record updated
- 17 November 2026